Skip to content

A clinical trial on the safety and effectiveness of composite hernia repair patch for preventing parastoma hernia

A clinical trial on the safety and effectiveness of composite hernia repair patch for preventing parastoma hernia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047379
Enrollment
Unknown
Registered
2021-06-13
Start date
2021-07-15
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parastoma hernia

Interventions

Experimental group:Preventive use of patch in colostomy
Control Group:General colostomy

Sponsors

Shanghai Pine&Power Biotech Co.,Ltd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years, no gender limit; 2. Requires elective permanent sigmoid colostomy surgery; 3. First time permanent sigmoid colostomy surgery; 4. In line with the American Society of Anesthesiologist score with I-III; 5. The patients or their guardians can understand the purpose of trial, be willing to cooperate surgery and follow-ups and voluntarily participate in the trial and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients whose life expectancy is less than 12 months; 2. Patients undergoing permanent colostomy in the emergency department; 3. Patients who have had other operations at the colostomy; 4. Patients with acute infections or poorly controlled lesions with skin diseases around the surgical incision; 5. Patients with a clear history of allergies to test materials (PLCL, fibrinogen); 6. Concomitant with various malignant tumors and chronic wasting diseases that cause cachexia and cannot tolerate surgery; 7. Patients with vital organ failure or other serious diseases; 8. Those who have participated in other clinical trials within the past 3 months; 9. The investigator judges that the patient has other factors that are not suitable for this test.

Design outcomes

Primary

MeasureTime frame
Effective rate of preventing parastoma hernia 12 months after operation;

Secondary

MeasureTime frame
Surgery success rate;Effective rate of preventing parastoma hernia at 6 months after operation;Quality of life score (SF-12 score);

Countries

China

Contacts

Public ContactCai Sanjun
caisanjun@gmail.com+86 13901815189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026